2001Zhonghua laonian yixue zazhiRequires access

Clinical value of serum CA_(125) determination for postmenopausal uterine endometrial carcinoma

Xinqian Ji

Open publisher page 0 citations

Abstract

Objective To assess preoperative value of serum CA 125 determination for uterine endometrial carcinoma including myometrial invasion, lymph node metastasis, surveillance and recurrence of the carcinoma. To explore the relationship between serum CA 125 levels and pathological grades of endometrial carcinoma. Methods Serum CA 125 levels were determined by ELISA test in 67 cases of postmenopausal endometrial carcinoma. Results There were significant differences in CA 125 levels between patients with clinical stage Ⅲ、 Ⅳ cases and clinical stage Ⅰ, Ⅱ ( P 0.01). Serum CA 125 levels of 10 cases with recurrent carcinoma were positive. Serum CA 125 levels of patients with papillary serous adenocarcinoma were significantly higher than those of adenocarcinoma. No relation was found between pathological grades and serum CA 125 levels. Conclusions Serum CA 125 levels was a useful clinical parameter for determination of postmenopausal endometrial carcinoma preoperatively.

About this research paper

What this paper is about

Objective To assess preoperative value of serum CA 125 determination for uterine endometrial carcinoma including myometrial invasion, lymph node metastasis, surveillance and recurrence of the carcinoma. To explore the relationship between serum CA 125 levels and pathological grades of endometrial carcinoma. Methods Serum CA 125 levels were determined by ELISA test in 67 cases of postmenopausal endometrial carcinoma. Results There were significant differences in CA 125 levels between patients with clinical stage Ⅲ、 Ⅳ cases and clinical stage Ⅰ, Ⅱ ( P 0.01). Serum CA 125 levels of 10 cases with recurrent carcinoma were positive. Serum CA 125 levels of patients with papillary serous adenocarcinoma were significantly higher than those of adenocarcinoma. No relation was found between pathological grades and serum CA 125 levels. Conclusions Serum CA 125 levels was a useful clinical parameter for determination of postmenopausal endometrial carcinoma preoperatively.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess preoperative value of serum CA 125 determination for uterine endometrial carcinoma including myometrial invasion, lymph node metastasis, surveillance and recurrence of the carcinoma. To explore the relationship between serum CA 125 levels and pathological grades of endometrial carcinoma. Methods Serum CA 125 levels were determined by ELISA test in 67 cases of postmenopausal endometrial carcinoma. Results There were significant differences in CA 125 levels between patients with clinical stage Ⅲ、 Ⅳ cases and clinical stage Ⅰ, Ⅱ ( P 0.01). Serum CA 125 levels of 10 cases with recurrent carcinoma were positive. Serum CA 125 levels of patients with papillary serous adenocarcinoma were significantly higher than those of adenocarcinoma. No relation was found between pathological grades and serum CA 125 levels. Conclusions Serum CA 125 levels was a useful clinical parameter for determination of postmenopausal endometrial carcinoma preoperatively.

Key concepts: Medicine, Carcinoma, Pathological, Stage (stratigraphy), Adenocarcinoma, Lymph node metastasis, Internal medicine, Metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical value of serum CA_(125) determination for postmenopausal uterine endometrial carcinoma — Research Paper | ScholarLens